1Murakami T, Takagi H, Kita M,et al. Intravitreal tissue plasminogen activator to treat macular edema associated with branch retinal vein occlusion. Am J Ophthalmol. 2006 Aug; 142(2): 318-20
2Weizer JS, Fekrat S. Intravitreal tissue plasminogen activator for the treatment of central retinal vein occlusion. Ophthalmic Surg Lasers Imaging. 2003 Jul-Aug;34(4):350-2
3Chen SN, Yang TC, Ho CL,et al. Retinal toxicity of intravitreal tissue plasminogen activator: case report and literature review. Ophthalmology. 2003 Apr; 110(4):704-8
4Nicolo M, Nasciuti F, Lai S,et al. Intravitreal triamcinolone acetonide as primary treatment for diffuse diabetic macular edema: a prospective noncomparative interventional case series. Eur J Ophthalmol. 2006 Jan-Feb;16(1):129-33
5Jonas JB, Akkoyun I, Kamppeter B,et al. Intravitreal triamcinolone acetonide for treatment of central retinal vein occlusion. Eur J Ophthalmol. 2005 Nov-Dec; 15(6):751-8
6Cekic O, Chang S, Tseng JJ,et al. Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion. Retina. 2005 Oct-Nov;25(7):846-50
7Tewari HK, Sony P, Chawla R,et al. Prospective evaluation of intravitreal triamcinolone acetonide injection in macular edema associated with retinal vascular disorders. Eur J Ophthalmol. 2005 Sep-Oct;15(5):619-26
8Williamson TH, O'Donnell A. Intravitreal triamcinolone acetonide for cystoid macular edema in nonischemic central retinal vein occlusion. Am J Ophthalmol. 2005 May,139(5):860-6
9Cheng KC, Wu WC. Intravitreal triamcinolone acetonide for patients with macular edema due to branch retinal vein occlusion: Kaohsiung J Med Sci. 2006 Jul;22(7):321-30
10Thompson JT. Cataract formation and other complications of intravitreal triamcinolone for macular edema. Am J Ophthalmol. 2006 Apr; 141 (4):629-37
